Related Experiment Video
Updated: May 7, 2026

Three-dimensional Confocal Analysis of Microglia/macrophage Markers of Polarization in Experimental Brain Injury
Published on: September 4, 2013
Clinical and prognostic profiles in immune-mediated hypertrophic meningitis: a retrospective analysis of 92 cases
Yifei Wang1, Yuyan Yang2, Xuemei Guo3
1Department of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, #1 Shuai-Fu-Yuan, Dongcheng District, 100730, Beijing, China.
Objectives:
Immune-mediated hypertrophic pachymeningitis (HP) is an inflammatory disorder with diverse neurological manifestations. Considering its various etiology and rarity, HP remains a diagnostic challenge. Comparisons of clinical and prognostic profiles across different etiologies remain insufficiently explored. We analyzed the clinical characteristics, treatment approaches, and outcomes of immune-mediated HP patients from a single center in China.
Method:
A retrospective study was conducted at Peking Union Medical College Hospital, analyzing immune-mediated HP cases from December 2003 to September 2021. We evaluated patients' neurological symptoms, systemic involvement, image findings, and baseline laboratory results, and compared these features among three predominant etiologies: antineutrophil cytoplasmic antibody (ANCA)-related HP, idiopathic HP, and IgG4-related disease (IgG4-RD). The treatment approaches and outcomes were also reviewed.
Results:
The study included 92 patients, 49 (53.3%) male and 43 (46.7%) female. ANCA-related HP was the leading cause of immune-mediated HP (n = 42, 45.6%), followed by idiopathic HP (n = 28, 30.4%), IgG4-RD (n = 12, 13.0%), and other underlying causes (n = 10, 10.9%). Despite different etiologies, similar patterns of cranial nerve and brain region involvement were observed. Large doses of glucocorticoids combined with immunosuppressants were the most common treatment across all etiologies. Kaplan-Meier analysis (mean follow-up time: 4.1 years) showed no significant differences in relapse-free survival rates among the three subgroups.
Conclusions:
ANCA-related HP, idiopathic HP, and IgG4-RD HP were the three predominant causes of immune-mediated HP in this Chinese cohort. The three etiologies exhibited similar clinical manifestations, imaging findings, and long-term prognoses, indicating that a standardized management strategy may benefit HP patients regardless of etiology. Key Points • Immune-mediated hypertrophic pachymeningitis (HP) is a rare disorder with diverse etiologies, and research comparing clinical and prognostic profiles across different causes remains limited. • This study involved 92 immune-mediated HP patients, comparing clinical characteristics, imaging findings, treatment approaches, and outcomes among ANCA-related, idiopathic, and IgG4-related HP. • The three predominant etiologies of HP showed similar clinical features and similar relapse-free survival rates. • Regardless of the underlying etiology, HP patients may benefit from a uniform management approach.
Insights
Immune-mediated hypertrophic pachymeningitis (HP) presents similarly across its main causes: ANCA-related, idiopathic, and IgG4-related disease. These diverse etiologies share comparable clinical features and long-term outcomes, suggesting a unified treatment approach may be beneficial.
Area of Science:
- Neurology
- Immunology
- Rheumatology
Background:
- Immune-mediated hypertrophic pachymeningitis (HP) is a rare inflammatory condition causing diverse neurological symptoms.
- Its rarity and varied causes present diagnostic challenges, with limited comparative studies on different etiologies.
- Understanding clinical and prognostic differences is crucial for effective management.
Purpose of the Study:
- To analyze and compare clinical characteristics, treatment strategies, and outcomes of immune-mediated HP patients.
- To investigate the predominant etiologies of HP in a Chinese cohort.
- To explore similarities and differences among antineutrophil cytoplasmic antibody (ANCA)-related HP, idiopathic HP, and IgG4-related disease (IgG4-RD).
Main Methods:
- A retrospective study of 92 immune-mediated HP cases from December 2003 to September 2021 at a single center in China.
- Evaluation of neurological symptoms, systemic involvement, imaging findings, and laboratory results.
- Comparison of clinical features, treatment approaches, and outcomes across ANCA-related HP, idiopathic HP, and IgG4-RD.
Main Results:
- Antineutrophil cytoplasmic antibody (ANCA)-related HP (45.6%) was the most common cause, followed by idiopathic HP (30.4%) and IgG4-related disease (13.0%).
- Despite differing etiologies, similar patterns of cranial nerve and brain region involvement were observed.
- The most common treatment involved high-dose glucocorticoids with immunosuppressants, and no significant differences in relapse-free survival were found among the subgroups after a mean follow-up of 4.1 years.
Conclusions:
- ANCA-related HP, idiopathic HP, and IgG4-RD HP are the primary causes of immune-mediated HP in this Chinese cohort.
- These etiologies demonstrate similar clinical manifestations, imaging findings, and long-term prognoses.
- A standardized management strategy may be effective for HP patients, irrespective of their underlying etiology.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Viral Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Encephalitis l: Introduction
Brain Abscess l: Introduction

